Hamilton BioVentures is a venture capital firm (with $100 million under management) investing in talented entrepreneurs bringing new Life Science technology enterprises to market. Hamilton BioVentures invests in companies developing dramatically better treatments (biopharmaceuticals and medical devices) for major human diseases and other medical conditions. Their investments generally take the form of direct equity in early-stage companies located on the West Coast.
|Transcept Pharmaceuticals||3/07||Series D||$40M||8|
|Troika Networks||7/05||Series B||$14.4M||5|